Morgan Stanley’s favorite AI stock is 92% exposed to the $1.6 trillion buildout it’s bullish on20 October 2026
Ex-OpenAI engineer accused of bugging office stays in jail as prosecutors allege Saudi ties20 October 2026
L.A. restaurant group’s $60,000 Kalshi trade shows how prediction markets are ‘bespoke insurance’19 October 2026
How Ketamine May Be The Answer To Treatment-Resistant DepressionBy Press Room9 April 2024 Although it is not yet approved by the FDA, off-label, supervised use of ketamine, a Schedule III substance, is allowed…